Maxipime/Piperacillin Combo Trial Kit from China
Clinical trial kit with piperacillin/tazobactam vials for double-blind studies on resistant infections. Still under HTS 3004.10.50.48 as measured-dose therapeutic medicaments, though chapter notes reference blinded kits in 3006. Specific combo dictates 3004 classification.
Duty Rate — China → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• IND exemption letter from FDA; declare as 'investigational use only'
• Secure chain of custody for blinded materials; IRB approval docs
• Avoid retail classification pitfalls by specifying trial context